AHCO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Adapthealth Corp (AHCO) does not present a strong buy opportunity for a beginner, long-term investor at this time. While the company's financials show modest growth and hedge funds are increasing their positions, the stock's recent price decline, lack of positive news catalysts, and absence of strong trading signals suggest waiting for a more favorable entry point.
The stock's technical indicators are mixed. The MACD is slightly positive but contracting, RSI is in the neutral zone at 37.314, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading close to its support level (S1: 9.885), and recent price action shows a significant decline (-4.27% in regular market trading).
Hedge funds are significantly increasing their positions, with a 1321.21% buying increase over the last quarter. The company's financials for Q3 2025 show revenue, net income, EPS, and gross margin growth YoY.
The stock has experienced a sharp price decline recently (-4.27% in regular market trading), and there are no recent news catalysts or congress trading data to support a bullish sentiment. Additionally, options data shows a high open interest put-call ratio (3.58), indicating bearish sentiment.
In Q3 2025, revenue increased by 1.79% YoY to $820.31M, net income rose by 7.29% YoY to $22.45M, EPS grew by 6.67% YoY to $0.16, and gross margin improved significantly by 32.31% YoY to 18.51%.
No recent analyst rating or price target changes were provided. The lack of updated analyst sentiment makes it challenging to gauge Wall Street's current outlook on the stock.
